{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,4,23]],"date-time":"2025-04-23T05:28:37Z","timestamp":1745386117989},"reference-count":0,"publisher":"Informa UK Limited","license":[{"start":{"date-parts":[[2015,11,1]],"date-time":"2015-11-01T00:00:00Z","timestamp":1446336000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/3.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["TCRM"],"DOI":"10.2147\/tcrm.s64915","type":"journal-article","created":{"date-parts":[[2015,11,2]],"date-time":"2015-11-02T17:48:54Z","timestamp":1446486534000},"page":"1657","source":"Crossref","is-referenced-by-count":4,"title":["New developments in the management of schizophrenia and bipolar disorder: potential use of cariprazine"],"prefix":"10.2147","author":[{"given":"Rafael","family":"Cove\u00f1as","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Felix-Martin","family":"Werner","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"301","published-online":{"date-parts":[[2015,11]]},"container-title":["Therapeutics and Clinical Risk Management"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.dovepress.com\/getfile.php?fileID=27805","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2016,10,30]],"date-time":"2016-10-30T18:59:11Z","timestamp":1477853951000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.dovepress.com\/new-developments-in-the-management-of-schizophrenia-and-bipolar-disord-peer-reviewed-article-TCRM"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,11]]},"references-count":0,"URL":"https:\/\/doi.org\/10.2147\/tcrm.s64915","relation":{},"ISSN":["1178-203X"],"issn-type":[{"value":"1178-203X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2015,11]]}}}